Androgenetic Alopecia
Conditions
Interventions
Treatment group:Using the Shupu Weiguangsu minimally invasive scalp treatment, the patients scalp is first cleaned and disinfected with ozone water. Then, the Shupu Scalp Infusion Device is used to pe
Sponsors
Xianyang Hospital, Yan'an University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: (1) Clinically diagnosed with androgenetic alopecia (meeting the diagnostic criteria of the "2023 Clinical Practice Guidelines: Diagnosis and Treatment of Androgenetic Alopecia"); (2) Have not used oral or topical hair loss treatments in the past six months; hair loss not caused by skin diseases such as leprosy or syphilis, trauma, or medications; not pregnant or breastfeeding. (3) Average age 18 to 60 years, any gender; (4) Voluntarily agree to participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Those with a history of androgenic alopecia for more than 10 years; (2) Those who have received other treatments in the past 3 months; (3) Those with a history of malignant tumors, platelet function disorders, anemia, or bleeding disorders; (4) HIV patients, or those positive for hepatitis B or hepatitis C; (5) Those with impaired immune function; (6) Those with active skin diseases or skin infections in the pre-treatment area; (7) Those taking nonsteroidal anti-inflammatory drugs; (8) Those prone to keloids.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall efficacy rate;Hair parameters (hair density, hair shaft diameter, vellus hair percentage); | — |
Secondary
| Measure | Time frame |
|---|---|
| Scalp symptom scores (folliculitis, greasiness, itching, dandruff);DLQI (Dermatology Life Quality Index) score;Patient satisfaction;Physician visual subjective assessment score; | — |
Countries
China
Contacts
Public ContactXiaoyan Chen
Xianyang Hospital, Yan'an University
Outcome results
None listed